21. Marlowe D, Crowne DP. Social desirability and response to perceived situational demands. J Consult Psychol. 1961;25:109-115.

22. Greenberg MA, Stone AA, Wortman CB. Health and psychological effects of emotional disclosure: a test of the inhibition-confrontation approach. J Pers Soc Psychol. 1996;71:588-602.

23. Horowitz M, Wilner N, Alvarez W. Impact of event scale: a measure of subjective stress. Psychosom Med. 1979;41:209-218.

24. Affleck G, Tennen H, Urrows S, Higgins P. Neuroticism and the pain-mood relation in rheumatoid arthritis: insights from a prospective daily study. J Consult Clin Psychol. 1992;60:119-126.

25. Pincus T, Callahan LF, Brooks RH, Fuchs HA, Olsen NJ, Kaye JJ. Self-report questionnaire scores in rheumatoid arthritis compared with traditional physical, radiographic, and laboratory measures. Ann Intern Med. 1989;110:259-266.

26. Tugwell P, Boers M, for the OMERACT Committee. Proceedings of the OMERACT conferences on outcome measures in rheumatoid arthritis clinical trials, Maastrict, the Netherlands. J Rheumatol. 1993;20:527-591.

27. Felson DT, Anderson JJ, Boers M, et al. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. Arthritis Rheum. 1993;36:729-740.

28. Paulus HE, Bulpitt KJ. Rheumatoid arthritis: outcome measures. Rheum Dis Clin North Am. 1995;21:605-618.

29. Pennebaker JW, Hughes CF, O'Heeron, RC. The psychophysiology of confession: linking inhibitory and psychosomatic processes. J Pers Soc Psychol. 1987;52:781-793.

30. Esterling BA, Antoni MH, Fletcher MA, Margulies S, Schneiderman N. Emotional disclosure through writing or speaking modulates latent Epstein-Barr virus antibody titers. J Consult Clin Psychol. 1994;62:130-140.

15